Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New patient-activated drug delivery system from Medtronic released in Europe

Dec. 5, 1996

Sterinetics System successfully inactivates multiple viruses in IVIg

Dec. 5, 1996

RTP to accelerate development of insoluble drug delivery technology

Dec. 5, 1996

Incyte and Abbott expand genomic database agreement

Dec. 5, 1996

Patent issued for Vical's core technology

Dec. 5, 1996

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Dec. 4, 1996

Forbes Medi-Tech awarded research grant

Dec. 4, 1996

BMS-Aurora research agreement on screening technology

Dec. 4, 1996

Zeneca and Rutgers collaborate on apoptosis research

Dec. 4, 1996

Incyte-Affymetrix to develop and commercialize new chip-based genomic databases

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...